ADPT

Adaptive Biotechnologies

• PUBT·6d ago

  Adaptive Biotech to present at William Blair Growth Stock Conference

• PUBT·05/19 12:08

  Artiva Biotherapeutics names Diego Miralles president, head of R&D

• Simply Wall St·05/19 08:35

  Is Adaptive Biotechnologies (ADPT) Attractively Priced After Recent Share Price Weakness?

• Seeking Alpha·05/18 10:50

  Cathie Wood’s weekly update: buys Cerebras, Tempus AI, sells AMD and TSM

• Dow Jones·05/12 16:31

  Adaptive Biotechnologies Is Maintained at Equal-Weight by Morgan Stanley

• Dow Jones·05/12 16:31

  Adaptive Biotechnologies Price Target Cut to $18.00/Share From $21.00 by Morgan Stanley

• Benzinga·05/12 16:22

  Morgan Stanley Maintains Equal-Weight on Adaptive Biotechnologies, Lowers Price Target to $18

• TipRanks·05/12 15:26

  Adaptive Biotechnologies price target lowered to $18 from $21 at Morgan Stanley

• TipRanks·05/12 11:30

  Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Biomea Fusion (BMEA) and Adaptive Biotechnologies (ADPT)

• Seeking Alpha·05/11 11:00

  Cathie Wood's weekly recap: buys TEM, WGS, and CRWV; sells AMD and RKLB

• Simply Wall St·05/10 14:30

  A Look At Adaptive Biotechnologies (ADPT) Valuation After Strong Q1 MRD Growth And Raised Full Year Guidance

• Simply Wall St·05/07 21:35

  Adaptive Biotechnologies Q1 Loss Deepens Again And Tests Profitability Improvement Narrative

• TipRanks·05/07 08:14

  Adaptive Biotechnologies price target lowered to $19 from $21 at JPMorgan

• Simply Wall St·05/06 20:32

  How Strong MRD Growth and Upgraded 2026 Guidance Will Impact Adaptive Biotechnologies (ADPT) Investors

• Dow Jones·05/06 20:27

  Adaptive Biotechnologies Is Maintained at Overweight by JP Morgan